At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 89 enrolled
Drug / intervention
sertraline +1 moredrug
Likely dose
sertraline 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.
Charles Drew University of Medicine and Science·interventional·Posted Feb 26, 2008·Updated Dec 12, 2017
In Brief
A Phase 4 clinical trial evaluating sertraline and Placebo for Diabetes and Depression. Completed, enrolled 89 participants across 1 site.
Detailed Summary
This proposed study will test the following hypothesis: Treating depression in Hispanics and African Americans with diabetes will improve their HbA1c and quality of life while on intervention and six months after intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Depression
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedFeb 2008
Primary CompletionOct 2008
TodayJul 2026
First PostedFeb 26, 2008
Enrollment StartSep 1, 2006
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 18.3 years ago
Interventions
sertralinedrug
50 mg up to 100 mg daily for 6 months
Placebodrug
50 mg up to 100 mg daily for 6 months